Pint Pharma Announces ORLADEYO Approval For HAE In Peru
09 Jul 2024 //
BUSINESSWIRE
Pint Pharma announces Orladeyo approval in Mexico for HAE prevention
14 May 2024 //
PHARMACEUTICAL TECHNOLOGY
Pint Pharma Announces ORLADEYO Approval In Mexico For HAE
13 May 2024 //
BUSINESSWIRE
Brazil Approves Pint`s ORLADEYO® For HAE In Adults, Kids ?12 Yrs
16 Apr 2024 //
BUSINESSWIRE
Empaveli is the first treatment for PNH that binds to the complement protein C3.
17 Oct 2023 //
BUSINESSWIRE